1-3 of 3
Nadia Gaudel
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Isatuximab subcutaneous in relapsed/refractory multiple myeloma: Exposure-response and serum m-protein dynamics analyses from phase 3 iraklia Study and the phase 1b Study

Free
Nadia Gaudel, Hoai-Thu Thai, Kamilia Abdelraouf, Jean-Baptiste Fau, Florence Suzan Teisserenc, Maya Stefanova-Urena, Dorothee Semiond
Journal: Blood
Blood (2025) 146 (Supplement 1): 5826.
https://doi.org/10.1182/blood-2025-5826
Published: 2025
Journal Articles

Model Based Approach to Evaluate Isatuximab Monthly Dosing Regimen in Relapsed/Refractory Multiple Myeloma Patients

Free
Hoai-Thu Thai, Nadia Gaudel-Dedieu, Marc Cerou, Bernard Sebastien, Helgi van de Velde, MD PhD, Dorothee Semiond, PhD PharmD, Christine Veyrat-Follet
Journal: Blood
Blood (2020) 136 (Supplement 1): 44.
https://doi.org/10.1182/blood-2020-139358
Published: 2020
Journal Articles

Exposure-Response Analyses and Disease Modeling for Selection and Confirmation of Optimal Dosing Regimen of Isatuximab in Combination Treatment in Patients with Multiple Myeloma

Free
Fatiha Rachedi, Kimiko Koiwai, Nadia Gaudel-Dedieu, Bernard Sebastien, Hoai-Thu Thai, Raouf El-Cheikh, Claire Brillac, Jean Baptiste Fau, Laurent Nguyen, Li Liu, Frank Campana, MD, Helgi van de Velde, MD PhD, Christine Veyrat-Follet, Dorothee Semiond, PhD PharmD
Journal: Blood
Blood (2019) 134 (Supplement_1): 1897.
https://doi.org/10.1182/blood-2019-128875
Published: 2019